Elevated C-reactive protein as a predictor of patient outcomes following palliative surgery

Journal of Surgical Oncology

Volumn 110, Issue 6, 2014, Pages 651-655

  Blakely, Andrew M ^a   Heffernan, Daithi S ^a   McPhillips, Jane ^a   Cioffi, William G ^a   Miner, Thomas J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

C reactive protein; Palliative surgery; Patient outcomes

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLEEDING; CANCER FATIGUE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; GASTROINTESTINAL OBSTRUCTION; HUMAN; MALE; OVERALL SURVIVAL; PAIN; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; WEIGHT REDUCTION; BLOOD; COMPLICATION; HEMORRHAGE; INTESTINAL OBSTRUCTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HEMORRHAGE; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PAIN; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84912024881     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23682     Document Type: Article

References (29)

1. Miner TJ, Brennan MF, Jaques DP: A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 2004;240:719-726, discussion 726-717.
2. Miner TJ, Jaques DP, Tavaf-Motamen H, et al.: Decision making on surgical palliation based on patient outcome data. Am J Surg 1999;177:150-154.
3. Miner TJ, Cohen J, Charpentier K, et al.: The palliative triangle: Improved patient selection and outcomes associated with palliative operations. Arch Surg 2011;146:517-522.
4. Miner TJ: Palliative surgery for advanced cancer: Lessons learned in patient selection and outcome assessment. Am J Clin Oncol 2005;28:411-414.
5. Thomay AA, Jaques DP, Miner TJ: Surgical palliation: Getting back to our roots. Surg Clin North Am 2009;89:27-41, vii-viii.
6. Allin KH, Nordestgaard BG: Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci 2011;48:155-170.
7. Koenig W, Sund M, Frohlich M, et al.: C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99:237-242.
8. Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
9. Lobo SM, Lobo FR, Bota DP, et al.: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-2049.
10. Castelli GP, Pognani C, Meisner M, et al.: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234-R242.
11. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002;420:860-867.
12. Mantovani A, Allavena P, Sica A, et al.: Cancer-related inflammation. Nature 2008;454:436-444.
13. Colotta F, Allavena P, Sica A, et al.: Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009;30:1073-1081.
14. Erlinger TP, Platz EA, Rifai N, et al.: C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-590.
15. Allin KH, Bojesen SE, Nordestgaard BG: Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009;27:2217-2224.
16. Khandavilli SD, Ceallaigh PO, Lloyd CJ, et al.: Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 2009;45:912-914.
17. Nozoe T, Matsumata T, Kitamura M, et al.: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335-338.
18. Nozoe T, Saeki H, Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001;182:197-201.
19. Koike Y, Miki C, Okugawa Y, et al.: Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 2008;98:540-544.
20. Ikeda M, Natsugoe S, Ueno S, et al.: Significant host-and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 2003;238:197-202.
21. Takeno A, Takiguchi S, Fujita J, et al.: Clinical outcome and indications for palliative gastrojejunostomy in unresectable advanced gastric cancer: Multi-institutional retrospective analysis. Ann Surg Oncol 2013;20:3527-3533.
22. Martin RC 2nd, Jaques DP, Brennan MF, et al.: Achieving RO resection for locally advanced gastric cancer: Is it worth the risk of multiorgan resection? J Am Coll Surg 2002;194:568-577.
23. Miner TJ, Jaques DP, Karpeh MS, et al.: Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 2004;198:1013-1021.
24. Volanakis JE: Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001;38:189-197.
25. Sansone P, Bromberg J: Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012;30:1005-1014.
26. Ernst M, Putoczki TL: Stat3: Linking inflammation to (gastrointestinal) tumourigenesis. Clin Exp Pharmacol Physiol 2012;39:711-718.
27. Hara M, Matsuzaki Y, Shimuzu T, et al.: Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 2007;27:3001-3004.
28. McMillan DC, Canna K, McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003;90:215-219.
29. Crumley AB, McMillan DC, McKernan M, et al.: An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 2006;94:1568-1571.